Key Financial Data Of Reporting Company

Astellas Pharma Inc. - Filing #7586679

Concept As at
2022-09-30
As at
2022-03-31
As at
2021-09-30
Key financial data of reporting company
Business results of reporting company
Cash and cash equivalents
361,073,000,000 JPY
315,986,000,000 JPY
318,295,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.